U.S. President threatened to destroy the country if Tehran makes no deal, but also suggested he might walk away from the ...
Announced partnership with Australian CRO to accelerate initiation of CLD-401 clinical trialThe Company has received feedback from the FDA through Type D interactions, and the Company believes its man ...
Deep learning in biopharma has come of age. After working for years to understand how to apply an artificial intelligence (AI) approach to biotechnology, Insilico Medicine recently announced the ...